Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters

Sanofi: Sarilumab reports positive results in three more phase III trials

BUY, Fair Value EUR106 (+16%)

Published last May Thursday 21, 2015
Bryan, Garnier & Co announces that the total proceeds of Galapagos IPO on Nasdaq, the largest Nasdaq IPO of a European biotech, have been raised to $317m following the full exercise of over-allotment option.

Bryan, Garnier & Co announces that the total proceeds of Galapagos IPO on Nasdaq, the largest Nasdaq IPO of a European biotech, have been raised to $317m following the full exercise of over-allotment option.

Published last May Tuesday 19, 2015
Bryan, Garnier & Co announces the successful follow-on offering of £20m for Advanced Oncotherapy plc

Bryan, Garnier & Co announces the successful follow-on offering of £20m for Advanced Oncotherapy plc

Published last May Monday 18, 2015

Bryan, Garnier & Co announces the successful $275m IPO of Galapagos NV, the largest Nasdaq IPO of European biotech

Published last May Thursday 14, 2015

Brief Comment - Compass Group: H1 results as expected after trading update on 30th March

Published last May Wednesday 13, 2015

Brief Comment - Essilor: Essilor interested in Rodenstock acquisition?

BUY, Fair Value EUR124 (+13%)

Published last May Tuesday 12, 2015

Axway Software: Jean-Marc Lazzari appointed new CEO

NEUTRAL, Fair Value EUR20 (-1%)

Published last May Tuesday 12, 2015

Indra Sistemas: Q1 15 results way below expectations, FY15 margin target reduced, no dividend

SELL, Fair Value EUR9.2 vs. EUR8.9 (-12%)

Published last May Tuesday 12, 2015

Carlsberg: Reported this morning, results ahead of expectations

NEUTRAL, Fair Value DKK634 (+2%)

Published last May Tuesday 12, 2015

LDR Holding: Strong growth from upcoming launches supported by increased commercial footprint

BUY, Fair Value USD46 vs. USD38 (+20%)

Published last May Monday 11, 2015

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities